Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial
Shinnosuke Yamaura et al · BMC · 2026
Accesso alla risorsa
Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.
Materiale supplementare disponibile
Riepilogo
Descripción general del contenido del recurso.
Come citare
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, S. Y. E. (2026). Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial. https://doi.org/10.1186/s40780-026-00562-6
MLA
al, Shinnosuke Yamaura et. "Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial." 2026. https://doi.org/10.1186/s40780-026-00562-6.
Chicago
al, Shinnosuke Yamaura et. 2026. "Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial.". https://doi.org/10.1186/s40780-026-00562-6.
Harvard
al, S. Y. E. 2026, Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial, BMC, available at: https://doi.org/10.1186/s40780-026-00562-6 [Accessed 8 Aug. 2026].
Dettagli della risorsa
Informazioni bibliografiche utili per verificare che sia il materiale corretto.
- Titolo
- Clinical assessment of blood glucose responses to 300-mg dose of L-theanine, an amino acid unique to green tea, in a fixed-sequence, two-period trial
- Autore / collaboratori
- Shinnosuke Yamaura et al
- Editore
- BMC
- Anno di pubblicazione
- 2026
- ISSN
- 2055-0294
- ISSN
- 2055-0294
- Lingua
- Inglés
Soggetti
Esplora risorse correlate a partire da questi soggetti.